NasdaqCM:XYLO - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	111	N/A	N/A	N/A	1
12/31/2024	105	N/A	N/A	N/A	1
6/30/2024	58	-16	-4	-4	N/A
3/31/2024	75	-16	-6	-5	N/A
12/31/2023	92	-16	-8	-6	N/A
9/30/2023	101	-15	-8	-6	N/A
6/30/2023	110	-14	-8	-6	N/A
3/31/2023	101	-12	-7	-6	N/A
12/31/2022	92	-10	-6	-6	N/A
9/30/2022	67	-8	-5	-5	N/A
6/30/2022	43	-7	-5	-5	N/A
3/31/2022	26	0	-8	-5	N/A
12/31/2021	10	7	-10	-5	N/A
9/30/2021	6	7	-10	-5	N/A
6/30/2021	3	8	-10	-5	N/A
3/31/2021	2	2	-8	-6	N/A
12/31/2020	1	-4	-6	-6	N/A
9/30/2020	0	-10	-5	-5	N/A
6/30/2020	0	-15	-4	-4	N/A
3/31/2020	0	-15	-3	-3	N/A
12/31/2019	0	-14	-3	-3	N/A
9/30/2019	0	-9	-4	-4	N/A
6/30/2019	0	-6	-4	-4	N/A
3/31/2019	0	-6	-4	-4	N/A
12/31/2018	0	-7	-4	-4	N/A
9/30/2018	0	-6	-4	-4	N/A
6/30/2018	0	-4	-4	-4	N/A
3/31/2018	0	-2	N/A	-5	N/A
12/31/2017	0	-3	N/A	-5	N/A
9/30/2017	0	-4	N/A	-5	N/A
6/30/2017	0	-5	N/A	-6	N/A
3/31/2017	0	-8	N/A	-7	N/A
12/31/2016	1	-9	N/A	-9	N/A
9/30/2016	1	-10	N/A	-11	N/A
6/30/2016	1	-10	N/A	-11	N/A
3/31/2016	1	-10	N/A	-10	N/A
12/31/2015	1	-10	N/A	-7	N/A
9/30/2015	1	-8	N/A	-6	N/A
6/30/2015	0	-7	N/A	-6	N/A
3/31/2015	0	-6	N/A	-5	N/A
12/31/2014	1	-6	N/A	-8	N/A
9/30/2014	1	-5	N/A	-7	N/A
6/30/2014	1	-5	N/A	-6	N/A
3/31/2014	1	-2	N/A	-1	N/A
12/31/2013	1	-1	N/A	-7	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if XYLO's forecast earnings growth is above the savings rate (2.6%).

Earnings vs Market: Insufficient data to determine if XYLO's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if XYLO's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: XYLO's revenue (34.4% per year) is forecast to grow faster than the US market (9.1% per year).

High Growth Revenue: XYLO's revenue (34.4% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if XYLO's Return on Equity is forecast to be high in 3 years time

Discover growth companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/20 02:59
End of Day Share Price	2024/12/20 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Xylo Technologies Ltd is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Rommel Dionisio	Aegis Capital Corporation
Jeffrey Cohen	Ladenburg Thalmann & Company
Christopher Lewis	Roth MKM

Xylo Technologies Future Growth

Future criteria checks 2/6

Key information

Recent future growth updates

Price target decreased to US$67.50

Consensus forecasts updated

Recent updates

First half 2024 earnings released: US$11.33 loss per share (vs US$13.39 loss in 1H 2023)

Full year 2023 earnings released: US$9.50 loss per share (vs US$6.04 loss in FY 2022)

Medigus Ltd.(NasdaqCM:MDGS) dropped from NASDAQ Composite Index

New minor risk - Financial data availability

Medigus Ltd. Announces Launch of Unique Pilot of A Wireless Charging Solution

New minor risk - Share price stability

New minor risk - Shareholder dilution

Medigus Ltd., Annual General Meeting, Aug 07, 2023

existing shareholders and office holders in ScoutCam acquired 46.11% stake in ScoutCam Inc. (OTCPK:SCTC) from Medigus Ltd. (NasdaqCM:MDGS) for $6 million.

M. Arkin (1999) Ltd. acquired 46.11% stake in ScoutCam Inc. (OTCPK:SCTC) from Medigus Ltd. (NasdaqCM:MDGS) for $6 million.

Full year 2022 earnings released: US$6.04 loss per share (vs US$4.42 profit in FY 2021)

Medigus Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

Price target decreased to US$67.50

Medigus says ScoutCam appoints Yehu Ofer as CEO

Consensus forecasts updated

First half 2022 earnings released: US$0.15 loss per share (vs US$0.44 profit in 1H 2021)

Medigus reports 1H results

What Does Medigus Ltd.'s (NASDAQ:MDGS) Share Price Indicate?

Medigus board files a motion to approve an up to $1.6M dividend distribution

Medigus Announces Receipt of Nasdaq Notice of Bid Price Deficiency

Medigus Ltd., Annual General Meeting, Jun 16, 2022

Is Now An Opportune Moment To Examine Medigus Ltd. (NASDAQ:MDGS)?

Full year 2021 earnings released: EPS: US$0.20 (vs US$0.65 loss in FY 2020)

Medigus Ltd. (NasdaqCM:MDGS) acquired a 35.1% stake in Fuel Doctor Holdings, Inc. (OTCPK:FDOC) for $0.26 million.

Medigus Ltd. Micro Mobility Vehicle JV, Revoltz, Launches Pilot Program At A New Autonomous Supermarket

A consortium of investors led by Medigus Ltd. (NasdaqCM:MDGS), L.I.A. Pure Capital Ltd. along with other buyers including a group of individuals completed the acquisition of ParaZero Technologies Ltd from Delta Drone International Limited (ASX:DLT).

Medigus Ltd. Announces First Authorization for Commercial Drone Deliveries in Brazil

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

High number of new directors

We Believe Medigus' (NASDAQ:MDGS) Earnings Are A Poor Guide For Its Profitability

First half 2021 earnings released: EPS US$0.44 (vs US$0.56 loss in 1H 2020)

Medigus Joint Venture, Revoltz Completes First Micromobility Vehicle Functional Prototype

Medigus jumps 4% as subsidiary Charging Robotics assigns first distributor for its wireless EV robotic charging pad

Medigus Ltd. announced delayed 20-F filing

Medigus Forms Joint Venture for the Development of Urban and Logistics Electric Vehicles with Emuze Founders

Medigus Ltd. Initiates Development of Robotic Wireless Charging Pad for Electric Vehicles

New 90-day high: US$3.69

Medigus launches ADS offering

Medigus Ltd. Enters the Wireless Charging Market for Electric Vehicle with New Autonomous Technology

Medigus expands EV operations with acquisition of autonomous technology, shares up 31%

Medigus Ltd. (TASE:MDGS) completed the acquisition of 50.01% stake in Purex Incorporated and Smart Repair Pro, Inc.

New finance cheif at Medigus

Tatiana Yosef to Step Down as Chief Financial Officer of Medigus Ltd., with Effect from January 15, 2021

Medigus Signs MOU to Enter Electric Vehicles and Electric Charging Market

Medigus shares +42% on plans to enter micro-mobility EV market

Medigus under pressure after increasing stake to ~33% in Polyrizon

Medigus Ltd. (TASE:MDGS) signed a share purchase agreement to acquire an unknown stake in Eventer Technologies Ltd.

Medigus Ltd. (TASE:MDGS) agreed to acquire additional 15.1% stake in Gix Internet Ltd (TASE:GIX).

Medigus Ltd. (TASE:MDGS) signed a non-binding letter of intent to acquire a controlling interest of 50.1% in Purex Incorporated and Smart Repair Pro, Inc. for $2.5 million.

Medigus Ltd. (TASE:MDGS) completed the acquisition of Linkury LTD. from Algomizer Ltd (TASE:ALMO).

Earnings and Revenue Growth Forecasts